TrialBone marrow transplantation2021

Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups.

Marie Robin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.